Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical and prognostic values of TP53 mutation in patients with B-lineage acute lymphoblastic leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 14 May 2021

Du Y Y, Lyu K K, Xu M M, Yao W Q, Kang H Z, Han Y, Tang X W, Ma X, Wu X J, He X F, Wu D P, Liu Y J

Abstract excerpt

Objective: To investigate the survival and prognosis of B-lineage acute lymphoblastic leukemia (B-ALL) patients with TP53 mutation. Methods: The clinical data of 479 newly diagnosed B-ALL patients treated in the First Affiliated Hospital of Soochow University from January 2016 to December 2019 were retrospectively analyzed. Results: Among 479 B-ALL patients, 34 cases (7.1%) were positive for TP53 gene mutation,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematopoietic Stem Cell Transplantation
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Prognosis

Share to Receptors, Chimeric Antigen

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 34218582
DOI: 10.3760/cma.j.issn.0253-2727.2021.05.008
PMCID: PMC8292997

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical and prognostic values of TP53 mutation in patients with B-lineage acute lymphoblastic leukemia].PMID 34218582Read ↗

Clinical Characteristics and Outcomes of Pediatric B-Cell Acute Lymphoblastic Leukemia Harboring TP53 Mutations: A Single-Center Retrospective Study.Semantic proximity Read ↗

[The effect of TP53 mutations on the clinical outcomes of Ph-negative B-acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation].Semantic proximity Read ↗

[Clinical and prognostic values of TP53 mutation in patients with acute myeloid leukemia].Semantic proximity Read ↗

Prognostic Impact of TP53 Mutations in Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemia: A Single-Center Study from ChinaSemantic proximity Read ↗

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.Semantic proximity Read ↗

Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.Semantic proximity Read ↗

Clinical Significance of TP53, PAX5, and JAK2 gene mutation in Pediatric Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Clinical Significance of TP53, PAX5, and JAK2 gene mutation in Pediatric Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis.Semantic proximity Read ↗

[Clinical Analysis of Gene Mutation in Adult Patients with B-ALL and Its Influence on Clinical Prognosis].Semantic proximity Read ↗

TP53 in adult acute lymphoblastic leukemia.Semantic proximity Read ↗

Impact of TP53 gene variants on prognosis and survival of childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.